In the Original Investigation titled “Yield and Utility of Germline Testing Following Tumor Sequencing in Patients With Cancer,”[1] published October 7, 2020, there was a numeric error in Table 1. The percentage of female patients given as 56.3 should have been 53.6. This article has been corrected.[1]
Authors: Stephen E Lincoln; Robert L Nussbaum; Allison W Kurian; Sarah M Nielsen; Kingshuk Das; Scott Michalski; Shan Yang; Nhu Ngo; Amie Blanco; Edward D Esplin Journal: JAMA Netw Open Date: 2020-10-01